Terms: = Liver cancer AND OMD, osteoadherin, 4958, ENSG00000127083, Q99983, SLRR2C
19 results:
1. REPeated mAgnetic resonance Image-guided stereotactic body Radiotherapy (MRIg-reSBRT) for oligometastatic patients: REPAIR, a mono-institutional retrospective study.
Chiloiro G; Panza G; Boldrini L; Romano A; Placidi L; Nardini M; Galetto M; Votta C; Campitelli M; Cellini F; Massaccesi M; Gambacorta MA
Radiat Oncol; 2024 Apr; 19(1):52. PubMed ID: 38671526
[TBL] [Abstract] [Full Text] [Related]
2. MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parameters.
van Overeem Felter M; Møller PK; Josipovic M; Bekke SN; Bernchou U; Serup-Hansen E; Madsen K; Parikh PJ; Kim J; Geertsen P; Behrens CP; Vogelius IR; Pøhl M; Schytte T; Persson GF
Radiother Oncol; 2024 Mar; 192():110090. PubMed ID: 38224916
[TBL] [Abstract] [Full Text] [Related]
3. Defining oligometastatic pancreatic cancer: a systematic review and critical synthesis of consensus.
Leonhardt CS; Stamm T; Hank T; Prager G; Strobel O
ESMO Open; 2023 Dec; 8(6):102067. PubMed ID: 37988953
[TBL] [Abstract] [Full Text] [Related]
4. liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study.
Kroese TE; Takahashi Y; Lordick F; van Rossum PSN; Ruurda JP; Lagarde SM; van Hillegersberg R; Verhoeven RHA; van Laarhoven HWM
Eur J Cancer; 2023 Jan; 179():65-75. PubMed ID: 36509000
[TBL] [Abstract] [Full Text] [Related]
5. Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer.
Inoue Y; Fujishima M; Ono M; Masuda J; Ozaki Y; Maeda T; Uehiro N; Takahashi Y; Kobayashi T; Sakai T; Osako T; Ueno T; Ohno S
Breast Cancer Res Treat; 2022 Nov; 196(2):341-348. PubMed ID: 36153381
[TBL] [Abstract] [Full Text] [Related]
6. A Comparison of 2 Disease Burden Assessment Methods (3D Volume Versus the Number of Lesions) for Prognostication of Survival in Metastatic Melanoma: Implications for the Characterization of Oligometastatic Disease.
Kim J; Chang JS; Sung W; Kim JS; Kim TH; Choi SH; Kim KH; Ko H; Lee HS; Jeon S; Shin SJ; Liu M; Olson R
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):883-891. PubMed ID: 36007725
[TBL] [Abstract] [Full Text] [Related]
7. A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for cancer Oligometastases.
Verma V; Yegya-Raman N; Sprave T; Han G; Kantarjian HM; Welsh JW; Chang JY; Lin SH
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):977-988. PubMed ID: 35675852
[TBL] [Abstract] [Full Text] [Related]
8. Development of an abdominal phantom for the validation of an oligometastatic disease diagnosis workflow.
Bauer DF; Rosenkranz J; Golla AK; Tönnes C; Hermann I; Russ T; Kabelitz G; Rothfuss AJ; Schad LR; Stallkamp JL; Zöllner FG
Med Phys; 2022 Jul; 49(7):4445-4454. PubMed ID: 35510908
[TBL] [Abstract] [Full Text] [Related]
9. Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis.
Kroese TE; van Laarhoven HWM; Nilsson M; Lordick F; Guckenberger M; Ruurda JP; D'Ugo D; Haustermans K; van Cutsem E; van Hillegersberg R; van Rossum PSN
Eur J Cancer; 2022 May; 166():254-269. PubMed ID: 35339868
[TBL] [Abstract] [Full Text] [Related]
10. Oligometastatic Colorectal cancer Management: A Survey of the Italian College of Interventional Radiology.
Calandri M; Gazzera C; Giurazza F; Yevich S; Strazzarino GA; Brino J; Marra P; Contegiacomo A; Bargellini I; Cariati M; Fonio P; Veltri A
Cardiovasc Intervent Radiol; 2020 Oct; 43(10):1474-1483. PubMed ID: 32449016
[TBL] [Abstract] [Full Text] [Related]
11. Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases.
Nicosia L; Cuccia F; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Bonù M; Corradini S; Tolia M; Alongi F
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2351-2358. PubMed ID: 32356176
[TBL] [Abstract] [Full Text] [Related]
12. Proposal for a definition of "Oligometastatic disease in pancreatic cancer".
Damanakis AI; Ostertag L; Waldschmidt D; Kütting F; Quaas A; Plum P; Bruns CJ; Gebauer F; Popp F
BMC Cancer; 2019 Dec; 19(1):1261. PubMed ID: 31888547
[TBL] [Abstract] [Full Text] [Related]
13. Tailoring ablation strategies for colorectal liver metastases based upon rat sarcoma viral oncogene mutation status.
Calandri M; Odisio BC
Chin Clin Oncol; 2019 Oct; 8(5):51. PubMed ID: 31500432
[TBL] [Abstract] [Full Text] [Related]
14. Local treatment of oligometastatic disease: current role.
Winkelmann MT; Clasen S; Pereira PL; Hoffmann R
Br J Radiol; 2019 Aug; 92(1100):20180835. PubMed ID: 31124700
[TBL] [Abstract] [Full Text] [Related]
15. Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinoma.
Gemenetzis G; Groot VP; Blair AB; Ding D; Thakker SS; Fishman EK; Cameron JL; Makary MA; Weiss MJ; Wolfgang CL; He J
J Surg Oncol; 2018 Dec; 118(8):1277-1284. PubMed ID: 30380143
[TBL] [Abstract] [Full Text] [Related]
16. Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir.
Shin JW; Jung SW; Lee SB; Lee BU; Park BR; Park EJ; Park NH
Am J Gastroenterol; 2018 Jul; 113(7):998-1008. PubMed ID: 29880971
[TBL] [Abstract] [Full Text] [Related]
17. Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma.
Teng Y; Fan YC; Mu NN; Zhao J; Sun FK; Wang K
Neoplasma; 2016; 63(3):419-26. PubMed ID: 26925788
[TBL] [Abstract] [Full Text] [Related]
18. Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis.
Liu W; Zhou JG; Sun Y; Zhang L; Xing BC
J Gastrointest Surg; 2015 Jul; 19(7):1271-80. PubMed ID: 25943910
[TBL] [Abstract] [Full Text] [Related]
19. Management of liver dominant metastatic breast cancer: surgery, chemotherapy, or hepatic arterial therapy - benefits and limitations.
Rodes Brown S; Martin RC
Minerva Chir; 2012 Aug; 67(4):297-308. PubMed ID: 23022754
[TBL] [Abstract] [Full Text] [Related]
